Study Stopped
Devices recall due to hermeticity problems.
Using Electrocochleography During Cochlear Implantation of the Neuro Zti.
PIC-22_eCoN
Using Electrocochleography to Guide Insertion of the Electrode Array During Cochlear Implantation of the Neuro Zti (eCoN)
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The main objective of this study is to evaluate the correspondence between eCochG and residual hearing by adding two modifications. First, a novel technique for placing and maintaining the probe in place during the whole insertion will be used. Second, a new metric for estimating the eCochG response will be evaluated (eCochG trauma index). The secondary objective is to find other markers of the cochlear trauma insertion associated to eCochG measures. This will be used to evaluate to which extend a traumatic insertion will be deleterious for the patient's post-operative hearing, and ultimately to prevent trauma to the inner ear. Finally, the potential differences in cochlear trauma resulting of the electrode array insertion from two different surgery techniques will be investigated; Either using a manual insertion or using a robotic arm that will drive the insertion automatically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedMarch 31, 2023
March 1, 2023
1 year
November 19, 2020
March 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation coefficient between the eCochG trauma index (in µV) and the residual hearing (in dB HL).
The eCochG trauma index correspond to electrophysiological changes of the cochlear response during the CI electrode insertion, and is calculated from the difference between post-insertion and pre-insertion eCochG measure (in µV). The hearing loss is calculated from the difference between the post-surgical and pre-surgical hearing thresholds (in dB HL). The correspondence is calculated from the correlation coefficient between the eCochG trauma index and the hearing loss. It is expected that a potential damage measured by the eCochG during the surgery have affected auditory threshold.
Through study completion, an average of 2 years
Secondary Outcomes (6)
Significant decrease of eCochG trauma index (in µV) for electrode array insertion performed manually compared to robotic.
Through study completion, average of 2 years
Correlation coefficient between the eCochG trauma index (in µV) and a misplacement of the electrode array inside the cochlea based on CT scan.
Through study completion, average of 2 years
Correlation coefficient between the eCochG trauma index (in nV) with the electrical charges (in nC) required to elicit eCAP threshold.
Through study completion, average of 2 years
Correlation coefficient between the eCochG trauma index (in nV) with impedance measurement (in Ω).
Through study completion, average of 2 years
Correlation coefficient between the eCochG trauma index (in nV) with fitting map electrical charges (in nC), and slopes of their growth functions.
Through study completion, average of 2 years
- +1 more secondary outcomes
Study Arms (2)
Manual Insertion
EXPERIMENTALThe surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole MANUAL insertion (by the surgeon).
Robotic insertion
EXPERIMENTALThe surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole ROBOTIC insertion.
Interventions
Before the mastoidectomy, the ear canal is cleaned, the insert earphone is connected to the Eclipse (Oticon Medical software) preamplifier and placed into the ear canal. The EEG scalp electrodes (active, ground electrode) are placed on the patient's head. After the posterior tympanotomy, the reference electrode (eCochG probe) is placed on the cochlear promontory. The CI electrode array will be inserted following one of the two possible techniques while the eCochG will be recording. The surgeon will either manually insert the array using the Oticon Medical stylet and following the surgery guides and recommendations from Oticon Medical or will control the Robotol insertion angle and drive the robotic arm in the same way.
Eligibility Criteria
You may qualify if:
- \> or equal 18 years ;
- Candidate for Neuro Zti EVO cochlear implant system, unilateral or bilateral recipient ;
- Preoperative residual hearing with audiometric thresholds less or equal than 80 dB at 500 Hz, or higher frequencies
You may not qualify if:
- Medical or psychological conditions which contraindicate surgery (e.g middle ear infection, tympanic membrane perforation) ;
- Patient with a psychological or linguistic inability to understand the information sheet ;
- Patient under legal protection or deprived of liberty
- Patient included and participating to another trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oticon Medicallead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yann YN Nguyen
Hôpital Pitié-Salpêtrière (Paris)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2020
First Posted
December 3, 2020
Study Start
January 1, 2023
Primary Completion
January 1, 2024
Study Completion
January 1, 2024
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share